Ironwood Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2020
Total Assets: $559.2M
Liabilities Breakdown FY2020
Total Liabilities: $496.6M
Asset Breakdown
Total Assets: $559.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $362.6M | 64.8% |
| Accounts Receivable | $122.4M | 21.9% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $8.9M | 1.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $65.4M | 11.7% |
Liabilities Breakdown
Total Liabilities: $496.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $661.0K | 0.1% |
| Long-Term Debt | $430.3M | 86.6% |
| Other Liabilities | $65.7M | 13.2% |